Category Intelligence on Home Nursing covers the following
The physical location of the study center is among the top three factors, which hinders patients in participating in a clinical trial.
Further, the time consumed during study visits and missed work also impacts the patient decision making hence the move towards home visit clinical trial is being welcomed in the industry to drive patient centricity.
The global home healthcare market is expected to reach USD 349.8 Billion by 2020 from USD 227.5 Billion in 2015, growing at a CAGR of 9.0 percent during the period 2015 to 2020.
The growth of this market is mainly driven by factors such as rising geriatric population across the globe, growing need of cost-effective healthcare delivery due to increasing healthcare costs, rising incidences of chronic diseases, and technological advancements in devices.
North America dominates the global home healthcare market owing to the presence of high sophisticated healthcare infrastructure, favorable reimbursement policies, increasing investment in R&D facilities, and presence of large number of small scale and large scale healthcare service providers.
Europe accounts for the second largest share of the total home healthcare market owing to increasing aged population, high prevalence of diabetes and cardiovascular diseases, and increasing healthcare investments by the European government.
Asia Pacific home healthcare market is expected to grow at a rapid pace owing to increasing geriatric population as elder people are prone to many disorders such as orthopedic, cardiovascular and others, rising awareness about the cost effectiveness and convenience
Patient Recruitment Barrier
The pricing depends on the company type with both fee for service and hourly rate being prevalent equally.
Complimentary 12-month access to Beroe LiVE
COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)